131 related articles for article (PubMed ID: 12509695)
21. Hypercalcaemia induced by excessive parathyroid hormone secretion in a patient with a neuroendocrine tumour.
Vacher-Coponat H; Opris A; Denizot A; Dussol B; Berland Y
Nephrol Dial Transplant; 2005 Dec; 20(12):2832-5. PubMed ID: 16188904
[No Abstract] [Full Text] [Related]
22. Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1.
Milanesi A; Yu R; Geller SA; Burton D; Deftos LJ; Wolin EM
Pancreas; 2011 May; 40(4):634-7. PubMed ID: 21483254
[TBL] [Abstract][Full Text] [Related]
23. Malignant islet cell tumor associated with hypercalcemia.
Mao C; Carter P; Schaefer P; Zhu L; Dominguez JM; Hanson DJ; Appert HE; Kim K; Howard JM
Surgery; 1995 Jan; 117(1):37-40. PubMed ID: 7809834
[TBL] [Abstract][Full Text] [Related]
24. Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton.
Stewart AF
J Bone Miner Res; 2002 May; 17(5):758-62. PubMed ID: 12009005
[TBL] [Abstract][Full Text] [Related]
25. Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas.
Iliuta IA; Beauregard JM; Couture F; Douville P; Mac-Way F
Clin Nucl Med; 2015 Sep; 40(9):e448-50. PubMed ID: 26053724
[TBL] [Abstract][Full Text] [Related]
26. Unusual complication of a pancreatic neuroendocrine tumor presenting with malignant hypercalcemia.
Kanakis G; Kaltsas G; Granberg D; Grimelius L; Papaioannou D; Tsolakis AV; Öberg K
J Clin Endocrinol Metab; 2012 Apr; 97(4):E627-31. PubMed ID: 22319031
[TBL] [Abstract][Full Text] [Related]
27. Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour.
Mantzoros CS; Suva LJ; Moses AC; Spark R
Clin Endocrinol (Oxf); 1997 Mar; 46(3):373-5. PubMed ID: 9156050
[TBL] [Abstract][Full Text] [Related]
28. Hypercalcaemia due to parathyroid carcinoma presenting in the third trimester of pregnancy.
Paul RG; Elston MS; Gill AJ; Marsh D; Beer I; Wolmarans L; Conaglen JV; Meyer-Rochow GY
Aust N Z J Obstet Gynaecol; 2012 Apr; 52(2):204-7. PubMed ID: 22188427
[TBL] [Abstract][Full Text] [Related]
29. Parathyroid hormone related protein and interleukin-6 mRNA expression in larynx and renal cell carcinomas from normocalcaemic and hypercalcaemic patients.
Schweitzer DH; Boxman IL; Löwik CW; van Krieken JH; Weissglas MG; Baatenburg de Jong RJ; Papapoulos SE
J Clin Pathol; 1995 Oct; 48(10):896-900. PubMed ID: 8537484
[TBL] [Abstract][Full Text] [Related]
30. Hypercalcaemia in small cell lung cancer: report of a case associated with parathyroid hormone-related protein (PTHrP).
Stuart-Harris R; Ahern V; Danks JA; Gurney H; Martin TJ
Eur J Cancer; 1993; 29A(11):1601-4. PubMed ID: 8217368
[TBL] [Abstract][Full Text] [Related]
31. Hypercalcaemia in a patient with fatal adenosquamous carcinoma of the colon.
Links M; Ho H; Clingan P; Diamond T
Med J Aust; 1994 Mar; 160(5):286-7. PubMed ID: 8107631
[TBL] [Abstract][Full Text] [Related]
32. Parathyroid hormone-related protein as a tumour marker in humoral hypercalcaemia associated with occult malignancy.
Hutchesson AC; Dunne F; Bundred NJ; Gee H; Ratcliffe WA
Postgrad Med J; 1993 Aug; 69(814):640-2. PubMed ID: 7880211
[TBL] [Abstract][Full Text] [Related]
33. Parathyroid hormone-related peptide mediates hypercalcemia in an islet cell tumor of the pancreas.
Mitlak BH; Hutchison JS; Kaufman SD; Nussbaum SR
Horm Metab Res; 1991 Jul; 23(7):344-6. PubMed ID: 1663481
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid hormone-related protein (PTHrP) gene expression in solid tumours associated with normocalcaemia and hypercalcaemia.
Dunne FP; Lee S; Ratcliffe WA; Hutchesson AC; Bundred NJ; Heath DA
J Pathol; 1993 Nov; 171(3):215-21. PubMed ID: 8277370
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic neuroendocrine tumor with extensive vascularisation and parathyroid hormone-related protein (PTHrP)--associated hypercalcemia of malignancy.
Clemens P; Gregor M; Lamberts R
Exp Clin Endocrinol Diabetes; 2001; 109(7):378-85. PubMed ID: 11573150
[TBL] [Abstract][Full Text] [Related]
36. [Hypercalcaemic crisis and acute renal failure due to primary hyperparathyroidism].
Georges CG; Guthoff M; Wehrmann M; Teichmann R; Gröne E; Artunc F; Risler T; Friedrich B; Müssig K
Dtsch Med Wochenschr; 2008; 133(Suppl 0):F3. PubMed ID: 19065508
[TBL] [Abstract][Full Text] [Related]
37. [Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias].
Minebois-Villegas A; Audran M; Lortholary A; Legrand E; Boux De Casson-Raimbeau F; Jallet P
Pathol Biol (Paris); 1995 Nov; 43(9):799-805. PubMed ID: 8746102
[TBL] [Abstract][Full Text] [Related]
38. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
39. Parathyroid hormone related protein in hypercalcaemia of Hodgkin's disease.
Bolo-Deoku J; Basu S; Lakhani S; Dunne F; Ratcliffe WA; Clarke M; Barron JL
J Clin Pathol; 1992 Jun; 45(6):541-2. PubMed ID: 1624608
[TBL] [Abstract][Full Text] [Related]
40. Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): Case Report.
Pitts S; Mahipal A; Bajor D; Mohamed A
Front Oncol; 2023; 13():1197288. PubMed ID: 37377908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
